Latest Sales Guidance News

James Hardie Industries reports a 34% jump in Q2 FY26 net sales driven by the AZEK acquisition and European growth, while grappling with margin pressures and integration costs.

Atomos Limited has upgraded its FY26 earnings guidance, forecasting significant sales growth and a return to EBITDA profitability driven by strong demand and a revamped sales strategy.

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.

Nova Eye Medical reported a 20% year-on-year revenue increase in Q1 FY26, reaffirming its FY26 sales guidance and targeting breakeven EBITDA by June 2026 amid cautious commercial expansion.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

Image Resources has trimmed its heavy mineral concentrate sales guidance for 2025 by around 9%, citing weaker demand and logistical challenges, while extending repayment terms on prepayment facilities.

Mount Gibson Iron suspends mining at Koolan Island following a significant rockfall, withdrawing FY26 sales guidance and initiating workforce reductions while advancing rehabilitation efforts.

Adairs Limited has updated its first half FY26 sales and gross margin guidance, reflecting moderated growth and mixed brand performances as it prepares for a critical peak trading period.

Iluka Resources has withdrawn its synthetic rutile sales guidance due to uncertainties stemming from Venator's sale and idling of its Greatham titanium dioxide facility. The move highlights growing market challenges and contract renegotiations in the pigment sector.

Santos Limited reported robust Q3 2025 results, highlighted by the Barossa LNG project commencing production and Pikka phase 1 nearing first oil. The company’s diversified portfolio and operational discipline underpin a confident outlook despite some operational delays.

Sheffield Resources achieved a record quarterly concentrate production at its Thunderbird mine but faces subdued zircon sales due to challenging market conditions in China, withholding December quarter guidance.

Nova Eye Medical has delivered solid FY25 results, meeting sales guidance outside China and achieving six consecutive halves of growth in the US market. The company also improved gross margins and reduced cash burn, setting an optimistic tone for FY26 with breakeven EBITDA guidance.